Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06789575

Comparison of Bupivacaine Wound Infiltration Versus Wound Instillation to Minimize Postoperative Pain After Thyroid Surgery

Status
Not Yet Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
102 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pain management following thyroidectomies, which can cause mild to moderate postoperative pain, particularly in the first 24 hours following surgery, has received little attention . The incision of the wound, neck hyperextension, retraction of the wound margins during surgery, and dissection are the main reasons of post-thyroidectomy discomfort . After thyroid surgery, pain management improves patients' quality of life and facilitates a speedy return to regular daily activities. the aim of the study to evaluate the effects of bupivacaine instillation after thyroidectomy against infiltration into the surgical field in order to reduce postoperative discomfort following thyroid surgery.

Detailed description

Pain management following thyroidectomies, which can cause mild to moderate postoperative pain, particularly in the first 24 hours following surgery, has received little attention . The incision of the wound, neck hyperextension, retraction of the wound margins during surgery, and dissection are the main reasons of post-thyroidectomy discomfort . After thyroid surgery, pain management improves patients' quality of life and facilitates a speedy return to regular daily activities.

Conditions

Interventions

TypeNameDescription
DRUGBupivacainethe patients will receive the content of a syringe (10 ml of bupivacaine 0.25%)
DRUGAdrenalinethe patients will receive the content of a syringe 15 μg adrenaline
DRUGLidocaine (drug)the patients will receive the content of a syringe 70 ml Lidocaine .

Timeline

Start date
2025-03-01
Primary completion
2026-03-01
Completion
2027-05-01
First posted
2025-01-23
Last updated
2025-01-23

Regulatory

Source: ClinicalTrials.gov record NCT06789575. Inclusion in this directory is not an endorsement.